Shopping Cart 0
Cart Subtotal
AED 0

Drug Screening Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 14676

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 18713

Details

Drug screening is used to detect illegal and some prescribed drugs in the blood, urine, and other biological samples. It is also used to determine drug use and is an integral part of ongoing evaluation and treatment. Rise in overuse of prescribed drugs, increase in use of narcotics and illicit drugs are some of the major driver for the market. For instance, as per Our World in Data, Illicit drug use is directly and indirectly responsible for over 750,000 deaths per year. Illicit drug use is responsible for 585,000 premature deaths by increasing the risk of disease and injury. Moreover, as per CDC in 2018, over 166,000 die from drug overdoses each year. In 2018, there were 67,367 drug overdose deaths in the United States, a 4.1% decline from 2017 (70,237 deaths). The age-adjusted rate of drug overdose deaths in 2018 (20.7 per 100,000) was 4.6% lower than in 2017 (21.7). For 14 states and the District of Columbia, the drug overdose death rate was lower in 2018 than in 2017. The rate of drug overdose deaths involving synthetic opioids other than methadone (drugs such as fentanyl, fentanyl analogs, and tramadol) increased by 10%, from 9.0 in 2017 to 9.9 in 2018. To curb the menace of drug and alcohol abuse, authorities in various countries are focusing on implementing comprehensive drug and alcohol testing measures. This has boosted the demand for drug and alcohol testing is expected to increase in the coming years.

Based on product and services, the global Drug Screening market is segmented into drug screening products and drug screening services. Currently, drug screening products dominated the market and is expected to maintain its dominance during the forecast period owing to the increased applications of rapid testing devices such as urine testing devices and oral fluid testing devices

Based on sample, the market is divided into urine samples, oral fluid samples, breath samples, hair samples, and other samples. Urine samples dominated the market in 2020 owing to the to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results

Based on end-users, the market is segmented into workplaces, drug testing laboratories, criminal justice systems & law enforcement agencies, hospitals, drug treatment centers, individual users, pain management centers, and schools & colleges. Currently workplace testing dominates the market and is expected to maintain its dominance during the analyzed period owing to the rowing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Drug Screening on account of rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening. However, Asia is expected to register the highest CAGR during the forecast period owing to the growing burden of accidents due to unsafe levels of alcohol consumption

Some of the major players operating in the market includes Siemens, Thermo Fisher, LabCorp, Alere, Omega Laboratories, Roche, OraSure, Biomedical Diagnostics, Quest Diagnostics, Laboratory Corporation of America Holdings; etc.

READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Drug Screening Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Drug Screening Market

2.1.1 Main Objective of the Global Drug Screening Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER DRUG SCREENING INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL DRUG SCREENING MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

8.1 Drug Screening Products

8.1.1 Analytical Instruments

8.1.1.1 Immunoassay Analyzers

8.1.1.2 Chromatography Instruments

8.1.1.3 Breathalyzers

8.1.2 Rapid Testing Devices

8.1.2.1 Urine Testing Devices

8.1.2.2 Oral Fluid Testing Devices

8.1.3 Consumables

8.1.3 Assay Kits

8.1.4 Sample Collection Tubes

8.1.5 Calibrators & Controls

8.1.6 Other Consumables

8.2 Drug Screening Services

9 MARKET INSIGHTS BY SAMPLE

9.1 Urine Samples

9.2 Oral Fluid Samples

9.3 Breath Samples

9.4 Hair Samples

9.5 Other Samples

10 MARKET INSIGHTS BY END-USERS

10.1 Workplaces

10.2 Drug Testing Laboratories

10.3 Criminal Justice Systems & Law Enforcement Agencies

10.4 Hospitals

10.5 Drug Treatment Centers

10.6 Individual Users

10.7 Pain Management Centers

10.8 Schools & Colleges

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA DRUG SCREENING MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE DRUG SCREENING MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC DRUG SCREENING MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD DRUG SCREENING MARKET

12 UROLOGY DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 DRUG SCREENING MARKET OPPORTUNITIES

17 DRUG SCREENING MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

18.2 Competitive Landscape

19.2.1 Company Shares, By Revenue

19 COMPANY PROFILED

19.1 Thermo Fisher

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings Revenue Split

19.1.4 Growth Strategy Financial Overview of Thermo Fisher

19.1.5 SWOT Analysis

19.1.6 Key Financials Product Launch

19.1.6.1 Partnerships

19.1.6.2 Business Expansion and Investments

19.1.7 Recent Developments Merger and Acquisition

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Siemens

19.3 LabCorp

19.4 Alere

19.5 Omega Laboratories

19.6 Roche

19.7 OraSure

19.8 Biomedical Diagnostics

19.9 Quest Diagnostics

19.10 Laboratory Corporation of America Holdings

20 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Siemens

Thermo Fisher

LabCorp

Alere

Omega Laboratories

Roche

OraSure

Biomedical Diagnostics

Quest Diagnostics

Laboratory Corporation of America Holdings

Company Profile

Company Profile Title

Drug screening is used to detect illegal and some prescribed drugs in the blood, urine, and other biological samples. It is also used to determine drug use and is an integral part of ongoing evaluation and treatment. Rise in overuse of prescribed drugs, increase in use of narcotics and illicit drugs are some of the major driver for the market. For instance, as per Our World in Data, Illicit drug use is directly and indirectly responsible for over 750,000 deaths per year. Illicit drug use is responsible for 585,000 premature deaths by increasing the risk of disease and injury. Moreover, as per CDC in 2018, over 166,000 die from drug overdoses each year. In 2018, there were 67,367 drug overdose deaths in the United States, a 4.1% decline from 2017 (70,237 deaths). The age-adjusted rate of drug overdose deaths in 2018 (20.7 per 100,000) was 4.6% lower than in 2017 (21.7). For 14 states and the District of Columbia, the drug overdose death rate was lower in 2018 than in 2017. The rate of drug overdose deaths involving synthetic opioids other than methadone (drugs such as fentanyl, fentanyl analogs, and tramadol) increased by 10%, from 9.0 in 2017 to 9.9 in 2018. To curb the menace of drug and alcohol abuse, authorities in various countries are focusing on implementing comprehensive drug and alcohol testing measures. This has boosted the demand for drug and alcohol testing is expected to increase in the coming years.

Based on product and services, the global Drug Screening market is segmented into drug screening products and drug screening services. Currently, drug screening products dominated the market and is expected to maintain its dominance during the forecast period owing to the increased applications of rapid testing devices such as urine testing devices and oral fluid testing devices

Based on sample, the market is divided into urine samples, oral fluid samples, breath samples, hair samples, and other samples. Urine samples dominated the market in 2020 owing to the to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results

Based on end-users, the market is segmented into workplaces, drug testing laboratories, criminal justice systems & law enforcement agencies, hospitals, drug treatment centers, individual users, pain management centers, and schools & colleges. Currently workplace testing dominates the market and is expected to maintain its dominance during the analyzed period owing to the rowing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Drug Screening on account of rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening. However, Asia is expected to register the highest CAGR during the forecast period owing to the growing burden of accidents due to unsafe levels of alcohol consumption

Some of the major players operating in the market includes Siemens, Thermo Fisher, LabCorp, Alere, Omega Laboratories, Roche, OraSure, Biomedical Diagnostics, Quest Diagnostics, Laboratory Corporation of America Holdings; etc.

READ MORE

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Drug Screening Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Drug Screening Market

2.1.1 Main Objective of the Global Drug Screening Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER DRUG SCREENING INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL DRUG SCREENING MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

8.1 Drug Screening Products

8.1.1 Analytical Instruments

8.1.1.1 Immunoassay Analyzers

8.1.1.2 Chromatography Instruments

8.1.1.3 Breathalyzers

8.1.2 Rapid Testing Devices

8.1.2.1 Urine Testing Devices

8.1.2.2 Oral Fluid Testing Devices

8.1.3 Consumables

8.1.3 Assay Kits

8.1.4 Sample Collection Tubes

8.1.5 Calibrators & Controls

8.1.6 Other Consumables

8.2 Drug Screening Services

9 MARKET INSIGHTS BY SAMPLE

9.1 Urine Samples

9.2 Oral Fluid Samples

9.3 Breath Samples

9.4 Hair Samples

9.5 Other Samples

10 MARKET INSIGHTS BY END-USERS

10.1 Workplaces

10.2 Drug Testing Laboratories

10.3 Criminal Justice Systems & Law Enforcement Agencies

10.4 Hospitals

10.5 Drug Treatment Centers

10.6 Individual Users

10.7 Pain Management Centers

10.8 Schools & Colleges

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA DRUG SCREENING MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE DRUG SCREENING MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC DRUG SCREENING MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD DRUG SCREENING MARKET

12 UROLOGY DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 DRUG SCREENING MARKET OPPORTUNITIES

17 DRUG SCREENING MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

18.2 Competitive Landscape

19.2.1 Company Shares, By Revenue

19 COMPANY PROFILED

19.1 Thermo Fisher

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings Revenue Split

19.1.4 Growth Strategy Financial Overview of Thermo Fisher

19.1.5 SWOT Analysis

19.1.6 Key Financials Product Launch

19.1.6.1 Partnerships

19.1.6.2 Business Expansion and Investments

19.1.7 Recent Developments Merger and Acquisition

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Siemens

19.3 LabCorp

19.4 Alere

19.5 Omega Laboratories

19.6 Roche

19.7 OraSure

19.8 Biomedical Diagnostics

19.9 Quest Diagnostics

19.10 Laboratory Corporation of America Holdings

20 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Siemens

Thermo Fisher

LabCorp

Alere

Omega Laboratories

Roche

OraSure

Biomedical Diagnostics

Quest Diagnostics

Laboratory Corporation of America Holdings